Patients with diabetes have impaired innate immunity, chronic inflammatory responses, increased coagulation activity, and decreased angiotensin-converting enzyme II expression, wherein using renin-angiotensin-aldosterone system antagonists results in a poor COVID-19 prognosis. This evidence concerns the gene REN and diabetes mellitus.